Skip to main content
Elshad Hasanov, MD, Oncology, Columbus, OH

ElshadHasanovMDPhD

Oncology Columbus, OH

Genitourinary Oncology

Assistant Professor

Dr. Hasanov is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Hasanov's full profile

Already have an account?

  • Office

    2255 Kenny Rd
    Columbus, OH 43221

Education & Training

  • University of Texas Health Science Center at Houston/M D Anderson Cancer Center
    University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2019 - 2022
  • University of Texas Health Science Center at Houston
    University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2017 - 2019
  • UMass Chan - Baystate
    UMass Chan - BaystateInternship, Surgery, 2016 - 2017
  • University of Texas M.D. Anderson Cancer Center
    University of Texas M.D. Anderson Cancer CenterPost-Doctoral Fellowship, 2012 - 2016
  • Texas A&M; Health Science Center College of Medicine
    Texas A&M; Health Science Center College of MedicinePost-Doctoral Fellowship, 2012 - 2016
  • Hacettepe University FOM
    Hacettepe University FOMClass of 2012

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2017 - Present
  • OH State Medical License
    OH State Medical License 2023 - 2025
  • MA State Medical License
    MA State Medical License 2016 - 2017
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Lectures

  • Hypoxia signaling and immune infiltration in a presurgical trial of sunitinib in patients with clear cell renal cell carcinoma (RCC). 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • AACR: Single-Cell Study Uncovers Distinct Immunosuppressive Tumor Microenvironment in Brain Metastases from Kidney Cancer
    AACR: Single-Cell Study Uncovers Distinct Immunosuppressive Tumor Microenvironment in Brain Metastases from Kidney CancerApril 18th, 2023

Professional Memberships